The synbiotic comprising two pills, each containing 4 10 9 CFU of Lactobacillus acidophilus CBT LA1, 4 10 9 of Lactobacillus casei CBT LC5, and 8 10 9 of Bifidobacterium lactis CBT BL3 together with 1.6 g of inulin was administered to non-dialyzed CKD patients in a 12-week randomized, double-blind, placebo-controlled study
A curated entry point for buyers comparing quality, documentation, and availability
In the literature: BPC-157 is a gastric-derived pentadecapeptide explored for angiogenesis pathway markers, endothelial migration assays, and ERK/Akt-eNOS pathway engagement in vitro and in rodent preclinical models
Access Considerations Lack of insurance coverage remains a major barrier for patients
Stop at least two months before trying to get pregnant